Cell-penetrating peptides (CPPs) are a promising group of delivery vectors for various therapeutic agents but their application is often hampered by poor stability in the presence of serum. Different strategies to improve peptide stability have been exploited, one of them being "retro-inversion" (RI) of natural peptides. With this approach the stability of CPPs has been increased, thereby making them more efficient transporters. Several RI-CPPs were here assessed and compared to the corresponding parent peptides in different cell-lines. Surprisingly, treatment of cells with these peptides induced trypsin insensitivity and rapid severe toxicity in contrast to L-peptides. This was measured as reduced metabolic activity and condensed cell nuclei, in parity with the apoptosis inducing agent staurosporine. Furthermore, effects on mitochondrial network, focal adhesions, actin cytoskeleton and caspase-3 activation were analyzed and adverse effects were evident at 20 μM peptide concentration within 4 h while parent L-peptides had negligible effects. To our knowledge this is the first time RI peptides are reported to cause cellular toxicity, displayed by decreased metabolic activity, morphological changes and induction of apoptosis. Considering the wide range of research areas that involves the use of RI-peptides, this finding is of major importance and needs to be taken under consideration in applications of RI-peptides.
Introduction
Cell-penetrating peptides (CPPs) are relatively short, cationic and/ or amphipathic peptides that have successfully been exploited to convey a wide range of cargos into different cell-lines in vitro, as well as in vivo. The major advantages associated with this class of delivery vectors, apart from their high delivery efficacy, is that they generally display low toxicity and that there appear to be no size restraints in terms of cargo compounds that can be transported into cells using these peptides [1] . One shortcoming, however, that has been realized in the last few years, is the frequent accumulation of CPPs in the endosomal compartments, which greatly reduces the bioavailability of the cargo molecules. Several different strategies have successfully been explored to overcome this problem, either by introducing chemical modifications in CPPs or by conjugating fusogenic peptides to CPPs [2, 3] . Another major issue that needs to be addressed is the rapid degradation of CPPs in the presence of serum. Almost all naturally occurring polypeptides are composed of L-amino acids and, consequently, the cellular proteolytic machinery does not recognize D-amino acids. Thus, substituting L-with D-amino acids in a peptide sequence increases its stability. This approach has proven successful for several CPPs, e.g. polyarginine, pVEC, and penetratin [4, 36, 5] . However, this conversion yields peptides which are enantiomers and, thus, the stereochemistry is not the same. Although making polyarginine and pVEC more stable and thereby more efficient transporters, the stereochemistry might be important for other CPPs. Furthermore, this modification is not suitable when the topology of the peptide is essential for activity.
In the early 1980s, Chorev and Goodman carried out extensive research on the chemistry of peptide backbone modifications [6] . They hypothesized that exchanging a natural peptide sequence with all-D amino acids (inverso) and reversing the order (retro) would yield a peptide with the same stereochemistry as the parent peptide. These peptidomimetics were named retro inverso (RI) peptides, where the side groups are oriented in the same way, but the amine and carbonyl of the amide peptide bond are reversed. In an extensive review from 2005, Chorev [7] presents a number of successful implementations of the RI concept. However, RI modification of natural peptides has a history of mixed success and several groups have reported that their RI-peptides lost the biological activity of the parent L-peptide [8, 9] . Also CPPs have been subjected to this modification, with the aim of producing transporters with increased stability. To our knowledge the only CPPs reported in the literature to have increased activity in their RI forms are the frequently used Tat [10] and penetratin peptides [11] .
The aim of our study was to increase the stability of a CPP (M918) designed in our lab, thereby making it a more potent transporter [12] . Another CPP (p14Arf), previously reported by our group to have apoptogenic effects was also subjected to the RI modification in order to enhance its efficacy [13] . The two most commonly used CPPs Tat and penetratin were studied in RI mode for comparison. The results indicate that cytotoxicity arises with RI-peptides above a certain length. Also the high number of hydrophobic amino acids in the peptide sequence might have a role in the induction of toxicity.
Materials and methods

Peptide synthesis
Peptides with either L-or D-amino acids, PNA and peptide-PNA conjugates were synthesized with t-Boc chemistry as described in [13] .
Cell culture
MCF-7 and MDA MB 231 (human breast cancer cell lines) cells (ATCC) were cultured in RPMI-1640 medium supplemented with FBS (10%), penicillin (100 U ml
), streptomycin (100 μg ml
), sodium pyruvate (1 mM), and non-essential amino acids (1%). HeLa pLuc 705 cells, kindly provided by R. Kole, were cultured in DMEM with glutamax, using the same supplements as above. HeLa cells were cultured in IMDM medium supplemented with FBS (10%), penicillin (100 U ml ) and streptomycin (100 μg ml
−1
). All cells were grown at 37°C and 5% CO 2 and all cell culture material were purchased from Invitrogen.
Cell proliferation assay
Cell proliferation was studied with the Roche Wst-1 proliferation assay according to the manufacturer's instructions (Roche Diagnostics Scandinavia AB, Sweden). Briefly, cells were seeded in 96 well plates 2 days prior the experiment to reach 80% confluency. Peptides were added at different concentrations in RPMI or IMDM medium (100 μl) followed by incubation for 4 h. The peptide solution was removed, fresh medium added and the incubation was continued for another 20 h. Wst-1 substrate (10 μl) (Roche) was added to every well and after 1-4 h absorbance was measured (450 nm) using Digiscan absorbance reader (Labvision via AH Diagnostics AB, Sweden). The percentage of viable cells was determined using GraphPad Prism software 4.0 (GraphPad Software, CA).
Membrane integrity assay
Membrane integrity was assessed using the Promega CytoTox ONE assay (Promega, Sweden). In brief, cells were seeded in 96-well plates two days prior the experiment to reach 80% confluency. Peptides were added at different concentrations in Hepes Krebs Ringer (HKR) (100 μl) and after 30 min incubation the exposure solution was transferred to a 96-well black plate, followed by addition of the CytoTox-ONE™ reagent. The plate was incubated for 10 min at RT and then fluorescence was measured (560/590 nm) with SPECTRAmax® GEMINI XS spectrofluorometric plate reader (Molecular Devices, USA). The results are presented as percentage of the maximum LDH release (100%) from 0.18% Triton X-100 treated cells.
Splice correction
60 000 HeLa pLuc 705 cells/well were seeded in 24-well plates. After 24 h, medium was removed and cells were overlaid with CPP-PNA conjugates at different concentrations in 500 μl optiMEM® reduced serum media (Invitrogen). Cells were incubated for 4 h whereafter 1 ml of full growth medium was added to each well. After an additional 20 h, medium was removed and cells were washed twice with HKR and subsequently lysed using 100 μl of 0.1% Triton X-100 in HKR. After 30 min incubation on ice, 20 μl cell lysates were transferred to white 96-well plates. Luciferase activity in cell lysates was measured on a Flexstation II (Molecular Devices, USA) using the Promega luciferase assay system according to manufacturers protocol (Promega) and normalized to protein content. ) was performed. Cells were mounted to 30% glycerol in PBS and imaged by Olympus FV1000 confocal microscope.
Fluorescence microscopy on live cells
8000 HeLa or MDA MB 231 cells/well were seeded onto 8-chambered cover glasses (Nalge Nunc International, NY) 2 days before experiment. Cells were incubated with 10 or 20 μM long RIand L-peptides, or 50 μM RI-short penetratin for either 3 h (MDA MB 231), visualized immediately after adding the peptides for 0-45 min (timelapse) or pulsed for 4 h and chased for additional 20 h (HeLa) at 37°C. 45 min prior to visualization, 10 nM MitoTracker (M7512, Molecular Probes, OR) was added. Cells were imaged using an Olympus FV1000 confocal microscope and images were analyzed with Olympus FV10 ASW software version 1.6.
Hoechst staining
Cells were seeded on cover slips in 24-well plates two days before the experiment, to reach a confluency of 70-80% on the day of the experiment. Peptides were added at different concentrations in RPMI medium and incubated for 4 h. The peptide solution was removed, fresh medium added and incubation continued for another 20 h. The coverslips were washed, fixed with 4% PFA, stained with Hoechst 33342 for 5 min at RT, washed, mounted on glass slides, and then analyzed by fluorescence microscopy (Leica DMIRE2 fluorescence microscope). Quantification of the cell images (n N 400 for each treatment) was done by counting the number of condensed and normal nuclei, then calculating the percentage of condensed nuclei and normalizing it against staurosporine treated cells.
Results
Cellular translocation of fluoresceinyl-labeled RI-CPPs
Five RI-peptides and their normal counterparts composed of L-amino acids were synthesized and evaluated in this study (Table 1) . To establish that the peptides retained their cell-penetrating ability after RI-isomerization, they were all labeled N-terminally with fluorescein and cellular uptake was confirmed with confocal microscopy. Within 30 min at 5 μM concentration, all peptides displayed a vesicular-like uptake pattern (data not shown).
Retro inversion of CPP does not confer increased cellular internalization
M918 is an efficient CPP recently discovered by EL Andaloussi et al. [12] . This peptide is capable of delivering various cargos including plasmids, proteins and oligonucleotides into a wide range of cell-lines. With the aim of making this CPP more stable, and thereby possibly more efficient, we synthesized its retro-inverso analogue. The splice correction assay has become a powerful method in evaluation of the delivery properties of CPPs since it generates a biological positive read-out (for a detailed description of the method, see [14, 15] ). This assay makes use of HeLa cells that are stably transfected with a luciferase reporter gene that is interrupted by a thalassemic intron carrying an aberrant splice site [15] . Under normal conditions, these HeLa pLuc 705 cells will produce luciferase transcripts carrying parts of the intron and concomitantly non-functional luciferase protein is produced. However, if a steric block splice-correcting oligonucleotide that binds complementary to the mutated position is introduced to the nucleus of cells, splicing will be re-directed and functional luciferase produced. Thus, by covalently conjugating RI-M918 to splice correcting antisense peptide nucleic acid (PNA) oligomer (Table 1 ) the delivery properties could be assessed by measuring the increase in luminescence. Surprisingly, RI-M918-PNA was not significantly better than M918-PNA at inducing splice correction at 2 and 5 μM, and at 10 μM correction was abolished when using RI-M918 whereas the parent M918-PNA promoted a further increase in splice correction (Fig. 1) . The drop in luminescence at 10 μM RI-M918 suggests that the cells are not viable and unable to produce luciferase.
RI-CPPs reduce the viability of cells
All peptides (Table 1) were assessed using the Wst-1 assay to determine their impact on cell viability. In our previous publication on the use of the p14Arf peptide [13] (from now on called Arf1-14), two different breast cancer cell-lines were used; MDA MB 231 and MCF-7. In order to compare the effects of RI-Arf1-14 and its parent peptide, the same cells were used and, in addition, the effect on HeLa cells was investigated, since this is one of the most commonly used cell-line. Staurosporine, an apoptosis-inducing agent, was included as control. None of the control peptides composed of L-amino acids reduced the viability of cells, and every RI-peptide was normalized against its L-peptide counterpart. In keeping with the results from the splice correction assay, RI-M918 reduced the cellular viability by 30% in HeLa cells at 10 μM (Supplementary Fig. S1b ), and the effect was even more pronounced in the other cell-lines (50-70% reduction) ( Fig. 2 and Supplementary Fig. S1a ). RI-Tat and RI-short penetratin were not toxic in the tested concentration range. However, full length RIpenetratin (RI-penetratin) had a dramatic effect on cellular viability. At 10 μM, it reduced the viability by 75% in MDA MB 231 cells (Fig. 2) . This is remarkable since staurosporine only reduced viability by 50%. The effect of RI-Arf1-14 was similar in both MDA MB 231 and MCF-7 cells, with 40-50% reduced viability at 10 μM concentration and 80-90% reduced viability at 20 μM ( Fig. 2 and Supplementary Fig.  S1a ). HeLa cells are more robust and although significant reduction in viability was observed, none of the RI-peptides reduced the viability by more than 50% (Supplementary Fig. S1b ).
To rule out that the observed toxic effects were due to extensive membrane damage after peptide treatment, leakage of lactate dehydrogenase (LDH) was measured. None of the peptides caused leakage above 8% in any of the tested cell-lines up to 20 μM concentration ( Supplementary Fig. S2a-c) .
RI-CPPs induce trypsin insensitivity of treated cells
The amount of apoptotic cells was initially assessed by the Annexin V assay. Surprisingly, cells treated with RI-CPPs did not detach from the plastic neither with enzymatic trypsin treatment nor with EDTA. The possibility of RI-peptides inhibiting the trypsin activity was assessed and no interference with its enzymatic activity was observed for any of the RI-peptides (data not shown). Therefore, to visualize the morphological changes in cells after RI-CPP treatment, MDA MB 231 and HeLa cells were incubated with 20 μM penetratin, RI-penetratin, Table 1 Names and sequences of the peptides and PNA used in the study. 
RI-CPPs prohibit formation of focal adhesions and induce disassembly of the actin cytoskeleton
Since trypsin had no effect on cells treated with RI-CPPs and that cells were firmly attached to the plastic even after longer enzymatic treatment, we investigated the condition of focal adhesions (FAs) in cells possessing the risen nucleus phenotype. For that, HeLa cells were incubated with 10 ( Supplementary Fig. S4 ) or 20 μM (Fig. 3) penetratin, RI-penetratin, Arf1-14 or RI-Arf1-14 for 4 h at 37°C and focal adhesion protein zyxin was visualized by immunofluorescence and microscopic analysis.
FAs in penetratin-and Arf1-14-treated cells were similar to control cells, where zyxin was located in short and relatively thick bundles ( Fig. 3 and supplemental Fig. S4 ). RI-penetratin, induced the formation of longer and thinner adhesive structures, especially when lower concentration (10 μM) was used.
RI-Arf1-14-treatment (20 μM) led to the disappearance of all FAs in cells possessing the risen nucleus phenotype (Fig. 3) . In the few cells (about 5%) still forming observable FAs after 10 μM RI-Arf1-14 treatment, the FAs were similar to those found in RI-penetratin treated cells with an extended and thinner appearance (Supplementary Fig. S4) .
The actin filaments, as one of the cellular cytoskeletal components responsible for cell stretching, adhesion and intracellular mechanical tension, terminate with focal adhesions at the cell membrane [16] . Since drastic alterations in adhesive structures were observed in RI-CPP-treated cells, we next analyzed the intactness of the actin cytoskeleton in MDA MB 231 and HeLa cells after treatment with 20 μM peptides for 4 h by visualizing the polymerized actin with the phalloidin-staining.
In MDA MB 231 cells, both RI-penetratin and RI-Arf1-14 dissociated the central actin filaments, leading to a diffuse unorganized localization of actin (Fig. 4) . The cortical actin fibers were, however, present in most of the RI-penetratin-treated cells. In contrast, when using RI-Arf1-14, the cortical actin bundles were missing in approximately 80-90% of cells. Additionally, the induction of filopodia-like structures was observed in RI-peptide-treated cells, especially with RI-Arf1-14, where the membrane area was undulating more as a result of the loss of stabilizing cortical actin. The L-counterpart peptides did not affect the cells and the actin skeleton was similar to control cells.
In HeLa cells, RI-penetratin-treatment destroyed most of the central actin filaments and led to the formation of large flat areas lined with numerous filopodia-like structures (Supplementary Fig. S5 ). RIArf1-14 affected both types of actin filaments, disassembling the cortical along with the central actin cables. Corroborating the results in MDA MB 231 cells, HeLa cells treated with penetratin and Arf1-14 did not appear different from the control cells.
RI-CPPs disrupt the mitochondrial network and induce apoptosis
In light of the extreme morphological and cytotoxic effects of the studied RI-peptides, we examined the integrity of the mitochondrial network in MDA MB 231 and HeLa cells using MitoTracker as a marker for active mitochondria. During early apoptotic events the inner mitochondrial transmembrane potential is disrupted [17] , leading to a decreased signal from the MitoTracker probe.
The L-peptides did not affect the mitochondrial potential neither in MDA MB 231 (Fig. 5 ) nor in HeLa cells (Supplementary Fig. S6 ). RI- peptides, on the other hand, exhibited a detrimental effect on the mitochondrial network already after 3 h, especially in MDA MB 231 cells (Fig. 5) . RI-penetratin-treatment caused disruption of the mitochondrial network in about 50% and RI-Arf1-14 in more than 95% of cells. In HeLa cells, RI-Arf1-14-treatment completely abolished the mitochondrial network. RI-penetratin had a much milder impact on HeLa cells and the mitochondrial network was still apparent (supplemental Fig. S6 ). The short penetratin analogue RI-short penetratin did not cause any visible discrepancies in the mitochondrial network compared to the untreated cells even at higher concentrations (50 μM) (Fig. 5) .
We also analyzed the effect of RI-Arf1-14 on the mitochondria in a time dependent manner and detected the first variations in mitochondrial signals already after 15-20 min (supplemental movie M2). The gaps in the network grew larger until completely disappearing after 45 min-1 h incubation. Along with the loss of mitochondrial signal, the cells underwent the morphological changes described above.
The observed nuclear changes and the possible involvement of apoptosis were further investigated by Hoechst staining of condensed nuclei. Cells treated with peptides, or staurosporine, were stained with Hoechst nuclear dye and analyzed by fluorescence microscopy. The L-peptides (M918, Arf1-14, penetratin and Tat) did not induce changes in nuclear morphology, while the RI-peptides (RI-M918, RIArf1-14 and RI-penetratin) induced chromatin condensation comparable with, or higher than, staurosporine. Cells treated with L-peptides or RI-Tat and RI-short penetratin displayed condensed nuclei in the same range as the untreated cells (Fig. 6 ).
RI-CPPs activate caspase-3
During apoptosis, several cellular caspases, e.g. caspase-3, are crucial mediators for inducing the programmed cell death [18] . Since the aforementioned alterations in cell viability, morphology, attachment and mitochondria refer to the induction of apoptosis, we studied the caspase-3 activation in MDA MB 231 and HeLa cells. The cells were treated with 20 μM penetratin, RI-penetratin, Arf1-14 or RI-Arf1-14, or 50 μM RI-penetratin and RI-short penetratin for 4 h. We observed a significant induction of caspase-3 activation in response to RI-Arf1-14-treatment in both cell lines (MDA MB 231 (Fig. 7) and HeLa ( Supplementary Fig. S7)) . Surprisingly, RI-penetratin did not induce activation of caspase-3 at 20 μM concentration, although slightly stronger fluorescence signal was detected in RI-penetratin-treated cells as compared to control or L-peptide-treated cells. However, increasing the concentration of RI-penetratin to 50 μM resulted in similar activation of caspase-3 as in RI-Arf1-14-treated cells. Similar effect was seen with RI-M918, where a higher concentration (50 μM) of the peptide was needed to induce caspase-3 activation (data not shown). On the other hand, neither RI-short penetratin (Fig. 7) nor RITat (data not shown) affected caspase-3 activation even at higher concentrations.
Discussion
The stability of the potent transport vectors called cell-penetrating peptides (CPPs) in the presence of serum or blood plasma has emerged as one of the limiting steps in their successful application in vivo [19] . To increase the peptide's resistance to premature degradation or proteolysis, several methods have been used, including D-isomerization and retro-inversion (RI) techniques. With the aim of improving the stability of a novel CPP called M918 displaying improved transporting abilities in different cell-lines [12] , we synthesized its RI counterpart. When assessing the transport efficiency of M918 and its RI-isoform, we unpredictably found that cells treated with RI-M918-PNA displayed drastic morphological changes, indicative of cytotoxicity.
Another effective CPP p14Arf, which has been shown to induce apoptosis, [13] was subjected to the RI isomerization. However, since it has been reported that the N-terminal 14 amino acids of p14Arf are sufficient for peptide activity [20] , we made p14Arf 1-14 in RI mode. As a control peptide, p14Arf1-14 with L-amino acids was synthesized. The initial results were promising since the cell-penetrating capability was retained and Wst-1 data showed that RI-Arf1-14 reduced the viability of MDA MB 231 and MCF-7 cells by 50% at 10 μM concentration ( Fig. 2 and Supplementary Fig. S1a ), without causing leakage of LDH (Supplementary Fig. S2 ). However, to ascertain that the reduced viability was not due to unspecific toxicity, but indeed due to the interaction of RI-Arf1-14 peptide with its target protein [13] , a control peptide was synthesized, where the five amino acids crucial for target interaction were inverted, producing a peptide with no effect on cell viability. Unexpectedly, this peptide caused an analogous reduction in cell viability as RI-Arf1-14 (data not shown), suggesting that the reduced proliferation was not due to RI-Arf1-14 per se, but more likely as a result of the RI modification of the peptide. In order to verify our findings, two widely used CPPs-Tat and penetratin-were synthesized in the RI-mode and analyzed for cytotoxicity. RI-penetratin was found to be as cytotoxic as RI-Arf1-14 and RI-M918, as determined with the Wst-1 assay (Fig. 2) , while RI-Tat did not affect the cells at all. In addition, we also found that cells treated with RI-Arf1-14, RI-M918 and RI-penetratin, could not be detached from the cell culture plates, neither with trypsin nor with EDTA. This observation, together with the results from splice correction and Wst-1 assays, were the first indications that RIpeptides might cause adverse cellular effects and it prompted us to investigate this phenomenon further.
Treatment of both MDA MB 231 and HeLa cells with RI-penetratin and RI-Arf1-14 induced extensive alterations in cell morphology. As depicted in Fig. 3 and 4 , the mechanism(s) behind these alterations may lie in the structural changes of the actin cytoskeleton and concomitantly the focal adhesions due to treatment with the RIpeptides. Since some CPPs have been demonstrated to directly interact with the monomeric actin [21] , they could, as a result, also interfere with the polymerization or rearrangement processes causing the above mentioned effects. Moreover, due to the increased stability of the RI-peptides, their effects inside the cells could be amplified by several fold because of their lack of removal by the cell's proteolytic machinery. Additionally, the actin cytoskeleton and its remodeling plays a crucial role in many cellular processes, i.e. cell spreading, adhesion, contraction, etc. [22] and, therefore, its disruption or depolymerization may lead to inhibition of cellular events resulting in abnormal functioning of the cell. For example, it has been shown that the actin cytoskeleton is involved in the cortical retraction of mitotic cells and in case of its disruption by inhibition of upstream effectors (i.e. RhoA and Rho-kinase/ROCK), the cells undergoing mitosis do not turn spherical [23] . Similar outcome was observed in our trypsin-treatment experiments, where cells without the presence of actin filaments did not obtain a globular form. Also, the risen nucleus of RI-peptide-treated cells is possibly caused by the disassembly of the actin skeleton since actin filaments are essential for nuclear positioning and anchorage [24] . Furthermore, it has been shown that actin disruption may evoke apoptosis [25] , affirming the damage that some of the RI-peptides cause the cells.
Adverse toxic effects were observed for all the RI-peptides, except for RI-Tat. Since RI-Tat is only 11 amino acids long, we hypothesized that this could be one of the reasons for the observed difference in toxicity of the RI-peptides. We therefore synthesized a truncated version of RI-penetratin with only the first 9 amino acids, named RIshort penetratin. This peptide was also nontoxic to the cells, suggesting that RI-peptides above a certain length cause these adverse effects. The importance of the peptide length on the cytotoxicity has been demonstrated before for e. g. polyarginine [26] . The length of the peptide may determine, for example, the depth of membrane insertion, since it has been demonstrated with Transportan (TP) [27] , that the longer peptides are capable of spanning the whole lipid bilayer, whilst shorter peptides can submerge only to the outer membrane leaflet. Additionally, the shortening of MAP peptide by four amino acid residues either N-or Cterminally (corresponding to the removal of one of the α-helix turns), eliminated its toxic effects [28] . The results on MAP indicate that there may be a correlation between helicity (a membrane interacting secondary structure) and cytotoxicity. We therefore hypothesize further that the ability to form secondary helical structure is important for efficient internalization but might also cause toxicity. Grounds for such hypothesis comes from the notion that all the toxic peptides used in this study-RI-Arf1-14, RI-penetratin, and RI-M918-contain amino acids that are frequently found within helices, e. g. alifatic amino acids, whereas RI-Tat is mostly composed of cationic residues that are less likely to form a helix. Also, both RI-Tat and RIshort penetratin are likely too short to form a secondary structure. Furthermore, as demonstrated by EL Andaloussi et al [29] , the quantitative uptake of Tat is about 50 times lower than penetratin at 5 μM, corroborating the result of many different groups that Tat peptide per se is not very potent in entering cells [30] [31] [32] . Therefore, the difference in toxicity displayed by the short versus the longer RIpeptides may additionally be due to higher intracellular levels of the latter.
Put together, the combination of peptide length, a high positive charge and existence of hydrophobic amino acids allowing the formation of regular secondary structures make the peptides more prone to first interact with the plasma membrane components, and second, associate better with the membrane lipids, leading to a stronger membrane perturbation ability. Since RI-Tat is devoid of hydrophobic amino acids that could potentially affect the membrane stability, it is not considered a membrane active peptide (at least in the concentration range used in this study). We have observed an increased membrane interaction with all the longer more hydrophobic RI-peptides by the induction of intracellular PI staining (data not shown). The fact that even though strong PI staining was recorded but LDH leakage was not observed during treatment with the toxic RICPPs indicates that the RI-peptides do not damage the membrane to the extent that large molecules could pass through the damaged regions. Instead, local disturbances of the lipid bilayer may be induced leading to the entrance of the small PI molecules. Taken together, because of both the length and the high number of hydrophobic amino acid residues in their sequence, the used (longer and hydrophobic) RI-CPPs may also interact and destabilize the intracellular mitochondrial membranes, causing the observed loss in the mitochondrial potential (Fig. 5, Supplementary Fig. S6 and movie M2 ). However, due to the lack of further evidence, we cannot rule out the possibility that RI-CPPs act indirectly upon the mitochondrial potential and activity. Nevertheless, the maintenance of the transmembrane potential is required for most mitochondrial functions and under apoptotic conditions the gradual loss of the mitochondrial membrane potential causes a decline in the generation of ATP and ultimately leads to cell death [33] . Therefore, the RI-peptidetreatment negatively affecting the mitochondrial network gives further evidence for cytotoxic effects of the RI-modification and may possibly refer to a process of apoptosis. Our results illustrate that changes in the mitochondrial network are actually the first signs of Fig. 7 . RI-Arf1-14 (20 µM) and RI-penetratin (50 µM) induce activation of caspase-3. Caspase-3 antibody with the secondary Alexa594-conjugated antibody was used to visualize activation of caspase-3 after peptide treatment. MDA MB 231 cells were incubated with 20 µM Arf1-14, RI-Arf1-14, penetratin, RI-penetratin or 50 µM RI-penetratin or 9-mer RIshort penetratin (here RI-short pen) for 4 h. Lower panels show DAPI stained cells. Control cells were incubated in RPMI medium without the peptides (no peptide). Bar 10 µm. cytotoxic activity displayed by the longer hydrophobic RI-peptides (observed already after 15 min, Supplementary movie M2), indicating that this could be the initiator of the successive events.
To define if the cells underwent apoptotic events after RI-peptide treatment, their nuclear morphology was characterized by Hoechst staining. All three RI-peptides which reduced the cell viability, RIArf1-14, RI-M918 and RI-penetratin, affected the cell nuclei in the same range as staurosporine (Fig. 6 ). This method is not specific enough to be used as a single approach to determine the involvement of apoptosis, but it provides general information if and to what extent the nuclei are affected. A more specific approach is to measure the activation of caspases, such as caspase-3. 20 μM RI-penetratin induced a weak, but measurable, activation of caspase-3 in MDA MB 231 cells (Fig. 7) . The same concentration of RI-Arf1-14, on the other hand, clearly activated caspase-3 in both MDA MB 231 and HeLa cells (Fig. 7 and Supplementary Fig. S7 ). Elevating the RI-penetratin concentration, however, induced the same extent of caspase-3 activation as observed in RI-Arf1-14-treated cells (Fig. 7) . Thus, the mechanism behind the toxic effects of RI-penetratin and RI-Arf1-14 differs or, alternatively, RI-penetratin is a less potent apoptosis inducing peptide. RI-Arf1-14 induced the same morphological changes as RIpenetratin, but the effect was faster and more severe with diminished focal adhesions and mitochondrial network. The diminished mitochondrial potential and the strong activation of caspase-3 after RIArf1-14 treatment in both MDA MB 231 and HeLa cells indicate that this peptide is most likely inducing its effect through apoptosis. However, caspase-3 activation is not an absolute requisite for definite induction of apoptosis and several caspase-independent cell death processes have been described [33] [34] [35] . Therefore, although RIpenetratin at lower concentrations did not activate caspase-3, it could still induce apoptosis through disruption of the mitochondrial potential and the actin cytoskeleton.
In summary, we hypothesize that the loss of mitochondrial transmembrane potential by RI-peptides could trigger the cascade of cellular events leading to the subsequent reduction of metabolic activity, actin depolymerization, trypsin insensitivity, nuclear condensation and caspase-3 activation. To our knowledge, this is the first time adverse toxic effects evoked by RI-peptides are documented. The RIisomerization has become a common way of increasing the stability of peptides, e.g. in the development of peptide vaccines and in the field of CPPs. Therefore, it is imperative that the adverse effects we have observed as a consequence of this modification become known.
Supplementary materials related to this article can be found online at doi:10.1016/j.bbamem.2010.10.019.
